GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 232 filers reported holding GENMAB A/S in Q4 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,749 | +402.8% | 1,127 | +441.8% | 0.00% | – |
| Q2 2023 | $7,906 | +79.0% | 208 | +77.8% | 0.00% | – |
| Q1 2023 | $4,417 | -52.6% | 117 | -46.8% | 0.00% | – |
| Q4 2022 | $9,322 | +86.4% | 220 | +27.9% | 0.00% | – |
| Q3 2022 | $5,000 | -68.8% | 172 | -64.5% | 0.00% | -100.0% |
| Q2 2022 | $16,000 | -72.4% | 485 | -69.5% | 0.00% | -66.7% |
| Q1 2022 | $58,000 | +5.5% | 1,590 | +11.5% | 0.00% | +50.0% |
| Q4 2021 | $55,000 | -9.8% | 1,426 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $61,000 | +6000.0% | 1,412 | +3822.2% | 0.00% | – |
| Q2 2021 | $1,000 | – | 36 | +50.0% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 24 | -96.0% | 0.00% | -100.0% |
| Q2 2020 | $20,000 | +66.7% | 596 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $12,000 | – | 596 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 52,148 | $1,839,260 | 1.67% |
| Ativo Capital Management LLC | 28,442 | $1,003,132 | 1.13% |
| HARDING LOEVNER LP | 3,204,230 | $113,013,183 | 0.75% |
| Hardman Johnston Global Advisors LLC | 592,318 | $20,891,056 | 0.70% |
| Yorktown Management & Research Co Inc | 16,600 | $585,482 | 0.66% |
| TORRAY INVESTMENT PARTNERS LLC | 104,516 | $3,686,279 | 0.65% |
| First Light Asset Management, LLC | 157,147 | $5,542,575 | 0.53% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 44,300 | $1,561,575 | 0.53% |
| Capricorn Fund Managers Ltd | 37,007 | $1,305,237 | 0.45% |
| Legacy Wealth Asset Management, LLC | 29,496 | $1,040,324 | 0.38% |